You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,470,842


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,470,842 protect, and when does it expire?

Patent 8,470,842 protects VARUBI and is included in two NDAs.

This patent has twenty-nine patent family members in fifteen countries.

Summary for Patent: 8,470,842
Title:Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza- -spiro[4.5]decan-2-one and preparation process therefor
Abstract: Disclosed are hydrochloride and tosylate crystalline salt forms of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-ph- enyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I and methods of preparing the same.
Inventor(s): Hu; Mengwei (Washington, NJ), Paliwal; Sunil (Monroe Township, NJ), Shih; Neng-Yang (Lexington, MA), Guenter; Frank Bruno (Schachen, CH), Mergelsberg; Ingrid (Mahwah, NJ)
Assignee: OPKO Health, Inc. (Miami, FL)
Application Number:12/614,108
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,470,842: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 8,470,842, providing a detailed analysis of its scope, claims, and the broader patent landscape.

What is United States Patent 8,470,842?

To begin, it is essential to identify the subject matter of the patent. However, since the specific details of Patent 8,470,842 are not provided in the sources, we will use general principles to analyze its scope and claims.

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the claims section of the patent, which outlines what is protected by the patent[3].

Metrics for Measuring Patent Scope

Researchers often use metrics such as independent claim length and independent claim count to measure patent scope. These metrics can indicate the complexity and breadth of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Claims Analysis

Independent Claims

Independent claims are standalone claims that define the invention without referencing other claims. They are critical in determining the patent's scope because they set the boundaries of what is protected.

Dependent Claims

Dependent claims, on the other hand, refer back to one or more independent claims and further limit the scope of the invention. They often provide additional details or variations of the invention.

Patent Landscape: Technology Areas and Trends

USPTO Classification

The U.S. Patent and Trademark Office (USPTO) classifies patents into various technology areas. These classifications help in understanding the broader trends in patenting. For example, patents can be grouped into engineering-related fields such as electrical and mechanical engineering, which made up about 60% of USPTO patents in 2018[1].

Industry Affiliation

The industry affiliation of inventors and assignees also provides valuable insights. For instance, firms in the computer and electronics manufacturing industry received a significant number of patents in 2017, reflecting their high R&D performance in the same year[1].

Determining Inventorship

True and Only Inventors

U.S. patent law requires that only the true and only inventors be listed on a patent application. This involves a two-step process: conception of the idea and reduction of the idea to practice. Correctly determining inventorship is crucial for maintaining the enforceability of the patent[5].

Patent Examination Process

Grant and Examination

The examination process at the USPTO involves evaluating the patent claims for novelty, non-obviousness, and utility. Narrower claims are often associated with a higher probability of grant and a shorter examination process, as they are more specific and less likely to be challenged[3].

International Comparisons

WIPO Classification

The World Intellectual Property Organization (WIPO) provides a classification system that allows for international comparisons of patent trends. This system includes 35 technical fields, which can be aggregated into broader technology areas for analysis[1].

Economic Impact

R&D Performance

High R&D industries tend to have high rates of patenting. For example, the computer and electronics manufacturing industry, which reported about $79 billion in domestic R&D performance in 2017, also received a significant number of patents in the same year[1].

Legal Considerations

Patent Quality Debates

There are ongoing debates about patent quality, with some arguing that patents have become overly broad, leading to increased licensing and litigation costs. However, these debates often lack well-defined measurements of patent scope[3].

Practical Applications

Searching and Analyzing Patents

Tools like the USPTO's Patent Public Search database and the PATENTSCOPE database from WIPO allow for full-text searching of patent grants and applications. These tools are essential for conducting thorough patent searches and analyzing the patent landscape[4].

Key Takeaways

  • Patent Scope: Determined by the claims section, with metrics like independent claim length and count used to measure breadth.
  • Claims Analysis: Independent claims define the invention, while dependent claims further limit the scope.
  • Technology Areas: Patents are classified into various technology areas, with electrical and mechanical engineering being prominent.
  • Inventorship: Correctly identifying true and only inventors is crucial for patent enforceability.
  • Examination Process: Narrower claims are associated with a higher grant probability and shorter examination.
  • International Comparisons: WIPO classification allows for global patent trend analysis.
  • Economic Impact: High R&D industries have high patenting rates.
  • Legal Considerations: Debates on patent quality highlight the need for clear scope measurements.

FAQs

What determines the scope of a patent?

The scope of a patent is determined by the claims section, which outlines what is protected by the patent. Metrics such as independent claim length and count can also be used to measure the breadth of the patent.

How are patents classified by the USPTO?

The USPTO classifies patents into various technology areas based on the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields.

Why is correct inventorship important?

Correct inventorship is crucial because it ensures the enforceability of the patent. Incorrect or incomplete identification of inventors can lead to challenges and potential invalidation of the patent.

What tools are available for searching and analyzing patents?

Tools like the USPTO's Patent Public Search database and the PATENTSCOPE database from WIPO allow for full-text searching of patent grants and applications.

How do narrower claims affect the patent examination process?

Narrower claims are associated with a higher probability of grant and a shorter examination process because they are more specific and less likely to be challenged.

Sources

  1. NCSES, "Invention: U.S. and Comparative Global Trends," January 15, 2020.
  2. USA.gov, "U.S. Patent and Trademark Office (USPTO)."
  3. SSRN, "Patent Claims and Patent Scope," September 29, 2016.
  4. Clemson University, "Research and Course Guides: Patent Searching, Advanced: Overview," May 23, 2024.
  5. Oregon State University, "Determining Inventorship for US Patent Applications."

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,470,842

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Tersera VARUBI rolapitant hydrochloride EMULSION;INTRAVENOUS 208399-001 Oct 25, 2017 DISCN Yes No ⤷  Subscribe ⤷  Subscribe PREVENTION OF DELAYED NAUSEA AND VOMITING ASSOCIATED WITH EMETOGENIC CANCER CHEMOTHERAPY ⤷  Subscribe
Tersera VARUBI rolapitant hydrochloride TABLET;ORAL 206500-001 Sep 1, 2015 RX Yes Yes ⤷  Subscribe ⤷  Subscribe PREVENTION OF DELAYED NAUSEA AND VOMITING ASSOCIATED WITH EMETOGENIC CANCER CHEMOTHERAPY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,470,842

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2004646 ⤷  Subscribe 300898 Netherlands ⤷  Subscribe
European Patent Office 2004646 ⤷  Subscribe PA2017031 Lithuania ⤷  Subscribe
European Patent Office 2004646 ⤷  Subscribe 122017000079 Germany ⤷  Subscribe
European Patent Office 2004646 ⤷  Subscribe 2017C/040 Belgium ⤷  Subscribe
European Patent Office 2004646 ⤷  Subscribe C201730041 Spain ⤷  Subscribe
European Patent Office 2004646 ⤷  Subscribe 17C1038 France ⤷  Subscribe
European Patent Office 2004646 ⤷  Subscribe 132017000117656 Italy ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.